Experts describe their hopes for the independent Australian Centre for Disease Control that will be established officially on ...

Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, ...

CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

As the Russia–Ukraine war kept borders uncertain, a quiet shift had begun: more Indian families were sending medical students ...

Vallerie McLaughlin, MD, the Kim A. Eagle M.D. Endowed Professor of Cardiovascular Medicine and professor of internal medicine at the University of Michigan Medical School, highlighted the need for ...

Renowned cardiologist Dr. Hosen Kiat bridges technology, biology, and integrative medicine—advancing global cardiovascular diagnostics and patient care.

Adults with atrial fibrillation who drank a cup a day of caffeinated coffee were less likely to have recurrent AF or atrial ...

The VISIONARY trial is testing sibeprenlimab, a humanized IgG2 monoclonal antibody, in patients with IgA nephropathy, a population at high risk for kidney failure.

UP DGME Debars 7 Candidates from CounsellingThe Directorate General of Medical Education and Training (UPDGME), Uttar Pradesh, has issued ...

Punjabi superstar Diljit Dosanjh earned official recognition in the Australian Senate for his record-breaking Aura Tour, celebrating Punjabi music’s global impact.

A prespecified analysis of the SURPASS-CVOT trial assessed the efficacy and safety of tirzepatide compared with dulaglutide on kidney outcomes in patients with very high-risk CKD and type 2 diabetes.

Outrage only on News18.com. Read Politics news, current affairs and news headlines online on Social Media-Outrage News today.